135 related articles for article (PubMed ID: 24155270)
21. Elevated substance P (NK-1) receptor immunoreactivity in the cerebellum of seizure prone gerbil.
Kim DS; Yoo KY; Hwang IK; Jung JY; Won MH; Seo JH; Kang TC
Neuropeptides; 2005 Feb; 39(1):9-14. PubMed ID: 15627495
[TBL] [Abstract][Full Text] [Related]
22. Activation of neurokinin-1 receptor by substance P inhibits melanogenesis in B16-F10 melanoma cells.
Ping F; Shang J; Zhou J; Song J; Zhang L
Int J Biochem Cell Biol; 2012 Dec; 44(12):2342-8. PubMed ID: 23041339
[TBL] [Abstract][Full Text] [Related]
23. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
Remröd C; Lonne-Rahm S; Nordlind K
Arch Dermatol Res; 2007 May; 299(2):85-91. PubMed ID: 17370082
[TBL] [Abstract][Full Text] [Related]
24. Observations favouring the occurrence of local production and marked effects of bombesin/gastrin-releasing peptide in the synovial tissue of the human knee joint--comparisons with substance P and the NK-1 receptor.
Grimsholm O; Rantapää-Dahlqvist S; Dalén T; Forsgren S
Neuropeptides; 2008 Apr; 42(2):133-45. PubMed ID: 18289674
[TBL] [Abstract][Full Text] [Related]
25. Neurokinin 1 receptor expression and substance P physiological actions are developmentally regulated in the rabbit retina.
Casini G; Dal Monte M; Fornai F; Bosco L; Willems D; Yang Q; Zhou ZJ; Bagnoli P
Neuroscience; 2004; 124(1):147-60. PubMed ID: 14960347
[TBL] [Abstract][Full Text] [Related]
26. Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study.
Myöhänen TT; Venäläinen JI; Garcia-Horsman JA; Männistö PT
Neuroscience; 2008 Jun; 153(4):1177-89. PubMed ID: 18455882
[TBL] [Abstract][Full Text] [Related]
27. Involvement of substance P and the NK-1 receptor in human pathology.
Muñoz M; Coveñas R
Amino Acids; 2014 Jul; 46(7):1727-50. PubMed ID: 24705689
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
Gitter BD; Bruns RF; Howbert JJ; Waters DC; Threlkeld PG; Cox LM; Nixon JA; Lobb KL; Mason NR; Stengel PW
J Pharmacol Exp Ther; 1995 Nov; 275(2):737-44. PubMed ID: 7473161
[TBL] [Abstract][Full Text] [Related]
29. Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway.
Bardelli C; Gunella G; Varsaldi F; Balbo P; Del Boca E; Bernardone IS; Amoruso A; Brunelleschi S
Br J Pharmacol; 2005 Jun; 145(3):385-96. PubMed ID: 15778738
[TBL] [Abstract][Full Text] [Related]
30. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists.
Cascieri MA; Shiao LL; Mills SG; MacCoss M; Swain CJ; Yu H; Ber E; Sadowski S; Wu MT; Strader CD
Mol Pharmacol; 1995 Apr; 47(4):660-5. PubMed ID: 7536886
[TBL] [Abstract][Full Text] [Related]
32. Substance P and the neurokinin-1 receptor in relation to eosinophilia in ulcerative colitis.
Jönsson M; Norrgård O; Forsgren S
Peptides; 2005 May; 26(5):799-814. PubMed ID: 15808910
[TBL] [Abstract][Full Text] [Related]
33. Cancer progression and substance P.
Coveñas R; Muñoz M
Histol Histopathol; 2014 Jul; 29(7):881-90. PubMed ID: 24535838
[TBL] [Abstract][Full Text] [Related]
34. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.
Lai JP; Ho WZ; Kilpatrick LE; Wang X; Tuluc F; Korchak HM; Douglas SD
Proc Natl Acad Sci U S A; 2006 May; 103(20):7771-6. PubMed ID: 16675550
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical characterization of substance P receptor (NK(1)R)-expressing interneurons in the entorhinal cortex.
Wolansky T; Pagliardini S; Greer JJ; Dickson CT
J Comp Neurol; 2007 May; 502(3):427-41. PubMed ID: 17366610
[TBL] [Abstract][Full Text] [Related]
36. Increased nuclear localization of substance P in human gastric tumor cells.
Muñoz M; Rosso M; Carranza A; Coveñas R
Acta Histochem; 2017 Apr; 119(3):337-342. PubMed ID: 28325510
[TBL] [Abstract][Full Text] [Related]
37. Rapid changes in substance P signaling and neutral endopeptidase induced by skin-scratching stimulation in mice.
Yamaoka J; Kawana S
J Dermatol Sci; 2007 Nov; 48(2):123-32. PubMed ID: 17692507
[TBL] [Abstract][Full Text] [Related]
38. Analysis on correlation between SP and NK-1R and intranasal mucosal contact point headache.
Zhao G; Yin J; Peng H; Wang J
Acta Otolaryngol; 2016; 136(5):522-7. PubMed ID: 26817501
[TBL] [Abstract][Full Text] [Related]
39. Expression and localization of NK(1)R, substance P and CGRP are altered in dorsal root ganglia neurons of spontaneously hypertensive rats (SHR).
Aline Boer P; Ueno M; Sant'ana JS; Saad MJ; Gontijo JA
Brain Res Mol Brain Res; 2005 Jul; 138(1):35-44. PubMed ID: 15869822
[TBL] [Abstract][Full Text] [Related]
40. Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease.
Liu L; Shang F; Markus I; Burcher E
J Pharmacol Exp Ther; 2002 Aug; 302(2):627-35. PubMed ID: 12130725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
